NCT03074357View on ClinicalTrials.gov

Urine, DNA and Clinical Information Collection From Patients With Alport Nephropathy.

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

March 23, 2018

Study Completion Date

March 23, 2018

Conditions
Alport Nephropathy
Trial Locations (1)

55455

Novartis Investigative Site, Minneapolis

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY